首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1736719

2026 年至 2032 年婦科設備市場（按產品、最終用戶和地區）

Gynecological Devices Market By Product (Surgical Devices, Handheld Instruments), By End-User (Hospital And Clinics, Ambulatory Surgery Centers (ASCs)), And Region for 2026-2032

出版日期: 2025年05月06日 | 出版商:

Verified Market Research | 英文 | 商品交期: 2-3個工作天內

價格

簡介目錄

婦科設備市場評估-2026-2032

3D內視鏡等先進影像工具的開發，以及有助於提高微創手術效果的婦科設備的改進，預計將推動該產業的發展。內視鏡檢查、腹腔鏡檢查、切除術和女性節育手術等外科手術數量的增加，預計將增加對這些產品的需求，預計到2023年，這些產品的價值將超過143.5億美元，到2032年將達到約325.2億美元。

除此之外，婦科疾病發生率的上升也有望在整個預測期內刺激市場擴張。此外，尖端和新技術的廣泛使用也有望推動產業擴張，使利基市場在2026年至2032年期間的複合年成長率達到10.77%。

全球婦科設備市場定義/概述

用於與女性生殖相關的外科手術、治療和診斷程序的各種醫療器械和設備被稱為婦科器械。婦科器械用於女性保健的各個方面。它們在婦科檢查中至關重要，有助於發現和診斷子宮內膜異位症、骨盆腔發炎和子宮頸癌等疾病。

婦科設備在各種婦科疾病的診斷、治療和監測中至關重要。它用於識別生殖器官異常、進行微創手術和實施避孕措施。例如，超音波掃描用於檢測卵巢囊腫和子宮肌瘤，而腹腔鏡檢查用於治療子宮內膜異位症和切除子宮肌瘤。

機器人輔助手術精度更高、恢復時間更短，預計將越來越受歡迎。數位影像技術將持續改進，從而實現更早的診斷和更準確的病情評估。此外，人工智慧 (AI) 與機器學習 (ML) 的融合有望透過提供個人化治療提案和改善患者預後，徹底改變婦科護理。

全球婦科疾病的增加如何推動全球婦科設備市場的成長？

婦科疾病的發生率不斷上升，以及人們對女性健康問題的認知不斷提高，推動著全球婦科設備市場的發展。隨著越來越多的女性尋求早期診斷和治療，該領域對先進醫療設備的需求也日益成長。根據世界衛生組織 (WHO) 的數據，截至 2024 年 3 月，子宮頸癌仍是全球女性第四大常見癌症，預計 2023 年新增病例將達 60.4 萬例。這凸顯了改善篩檢和治療技術的需求。

微創手術和診斷工具的技術進步正在擴展婦科設備的功能。對於醫療保健提供者而言，這些創新轉化為改善患者預後、縮短復原時間並提高手術效率。 2024年2月，美國食品藥物管理局）報告稱，新婦科設備的核准與前一年同期比較增加了22%。

女性人口老化以及由此導致的與老齡化相關的婦科疾病的增多，正在推動市場成長。隨著預期壽命的延長，對治療骨盆器官脫垂和尿失禁等問題的器械的需求也隨之成長。美國人口普查局預測，到2030年，所有嬰兒潮世代都將達到或超過65歲，這將擴大最有可能需要婦科干預的人群範圍。

嚴格的政府規章制度將如何阻礙全球婦科設備市場的成長？

監管障礙和嚴格的核准流程對全球婦科器械市場構成了重大挑戰。製造商必須透過複雜且通常冗長的監管途徑將新器械推向市場，這可能會減緩創新並增加成本。根據美國食品藥物管理局，截至 2024 年 6 月，婦科器材 510(k) 核准的平均時間為 177 天，與前一年同期比較增加了 15%。

新興國家醫療保健和婦科服務可近性有限，阻礙了其發展。許多中低收入國家的女性在獲得充足的婦科護理方面面臨障礙，包括缺乏訓練有素的醫療保健人員和充足的醫療基礎設施。世界衛生組織（WHO）於2024年3月報告稱，開發中國家只有62%的女性能夠接受定期婦科檢查。

對某些婦科器材安全性和有效性的擔憂，導致審查力道加大，市場也因此猶豫不決。過去圍繞著經陰道網片植入物等器械的爭議，提高了患者和醫療保健提供者的認知度，影響了新技術的採用率。美國政府責任署 (美國 Government 課責 Office) 於 2024 年 2 月報告稱，過去兩年，與婦科器械相關的不利事件報告增加了 22%。

The development of sophisticated imaging tools like 3D endoscopes and improvements in gynaecological equipment that help to increase the effectiveness of minimally invasive surgical techniques are anticipated to propel the growth of the industry. The demand for the product is anticipated to rise due to the rising number of surgical operations, including endoscopy, laparoscopy, ablation, and female sterilization, surpassing USD 14.35 Billion valued in 2023 to reach a valuation of around USD 32.52 Billion by 2032.

In addition to this, the rising incidence of gynaecological problems is anticipated to fuel market expansion throughout the projected period. The increasing use of cutting-edge and novel technology is also anticipated to fuel industrial expansion, thus enabling the niche market grow at a CAGR of 10.77% from 2026 to 2032.

Global Gynecological Devices Market: Definition/ Overview

A wide range of medical tools and equipment used for surgical, therapeutic, and diagnostic procedures pertaining to women's reproductive health are referred to as gynecology devices. Gynecological devices are used in many aspects of women healthcare. They are crucial in gynecological exams, aiding in the detection and diagnosis of diseases such as endometriosis, pelvic inflammatory disease, and cervical cancer.

Gynaecology devices are indispensable in the diagnosis, treatment, and monitoring of various gynaecological conditions. They are used to identify abnormalities in the reproductive organs, perform minimally invasive surgeries, and provide contraception. For instance, ultrasound is employed to detect ovarian cysts and uterine fibroids, while laparoscopy is used to treat endometriosis and remove uterine fibroids.

Robotic-assisted surgery is expected to become increasingly prevalent, offering greater precision and reducing recovery time. Digital imaging techniques will continue to improve, enabling earlier diagnosis and more accurate assessment of conditions. Moreover, the integration of artificial intelligence (AI) and machine learning (ML) has the potential to revolutionize the gynecological care by providing personalized treatment recommendations and improving patient outcomes.

How the Rising Cases of Gynecological Disorders Worldwide Boosting the Growth of Global Gynecological Devices Market?

The increasing prevalence of gynecological disorders and the growing awareness of female health issues are driving the global Gynecological Devices Market. As more women seek early diagnosis and treatment, the demand for advanced medical devices in this field continues to rise. According to the World Health Organization, as of March 2024, cervical cancer remains the fourth most common cancer among women globally, with an estimated 604,000 new cases in 2023. This underscores the need for improved screening and treatment technologies.

Technological advancements in minimally invasive procedures and diagnostic tools are expanding the capabilities of gynecological devices. These innovations offer improved patient outcomes, reduced recovery times, and increased procedural efficiency for healthcare providers. The U.S. Food and Drug Administration reported in February 2024 that approvals for novel gynecological devices increased by 22% compared to the previous year.

The aging female population and the subsequent increase in age-related gynecological conditions are fueling market growth. As life expectancy increases, there is a greater need for devices that address issues such as pelvic organ prolapse and urinary incontinence. The U.S. Census Bureau projects that by 2030, all baby boomers will be older than 65, expanding the demographic most likely to require gynecological interventions.

How the Stringent Government Rules and Regulations Hampering the Global Gynecological Devices Market Growth?

Regulatory hurdles and stringent approval processes pose significant challenges for the global Gynecological Devices Market. Manufacturers must navigate complex and often lengthy regulatory pathways to bring new devices to market, which can delay innovation and increase costs. According to the U.S. Food and Drug Administration, as of June 2024, the average time for 510(k) clearance for gynecological devices was 177 days, a 15% increase from the previous year.

Limited access to healthcare and gynecological services in developing regions hinders market growth. Many women in low- and middle-income countries face barriers to receiving proper gynecological care, including a lack of trained healthcare providers and adequate medical infrastructure. The World Health Organization reported in March 2024 that only 62% of women in developing countries have access to regular gynecological screenings.

Concerns over the safety and efficacy of certain gynecological devices have led to increased scrutiny and potential market hesitation. Past controversies surrounding devices like transvaginal mesh implants have resulted in heightened awareness among patients and healthcare providers, impacting adoption rates of new technologies. The U.S. Government Accountability Office reported in February 2024 that adverse event reports related to gynecological devices increased by 22% over the past two years.

Category-Wise Acumens

What are the Features Bolstering the Growth of Surgical Devices Segment?

The surgical devices are emerging as a dominating segment in the global gynecology devices market, driven by technological advancements and an increasing prevalence of gynecological disorders. According to a recent report by the World Health Organization (WHO) published in March 2024, approximately 35% of women worldwide will undergo a gynecological surgical procedure in their lifetime, underscoring the critical role of these devices in women's healthcare.

Market leaders in the gynecology devices sector continue to innovate and expand their product offerings to meet growing demand. For instance, on September 15, 2024, Medtronic, a key player in the market, announced the launch of its next-generation robotic-assisted surgical system specifically designed for gynecological procedures. This cutting-edge technology promises to enhance precision and outcomes in complex surgeries, further solidifying the position of surgical devices segment at the forefront of the Global Gynecology Devices Market.

How will the Adoption of Advanced Technologies by Hospitals & Clinics Projects the Market Growth?

The hospitals & clinics segment is estimated to dominate the global Gynecological Devices Market growth during the forecast period. The rising need for gynaecological procedures and the use of cutting-edge technologies in clinics and hospitals are the primary causes of the high share. For instance, on January 2022, The Women's Hospital at Jackson Memorial, HCA Florida Healthcare's Kendall Regional Medical Center, and AdventHealth Celebration began utilizing Memic Innovative Surgery's Hominis Surgical System, a robotic surgical device, for gynaecological procedure.

The needs of women healthcare have grown as their lives have changed. With women becoming more conscious of their health and wellbeing, there has been a growing need for improved gynecological therapies. Acknowledging this potential, global medical device manufacturers have developed innovative gynecology gadgets that are painless and effective, enabling patients to heal quickly.

North America Region?

The North America is emerging as the dominating region in the global Gynecological Devices Market. Due to the rising incidence of cancer linked to gynecology, the prominence of device makers, and improvements in technology, the North American area currently owns the greatest proportion of the global market for gynecological devices. An expected 65,950 new instances of uterine corpus cancer were detected in the US in 2022, according to the American Cancer Society. Cervical cancer is the most concerning of all the cancers, and its incidence in American women is rising quickly. In the US, 14,100 cases of cervical cancer are anticipated in 2022.

In addition to this, an update from the Canadian Cancer Society in 2022 projects that 8,100 Canadian women would likely receive a uterine cancer diagnosis in 2022. As a result, the need for gynecological equipment in the nation is increasing due to the increased prevalence of cancer. Moreover, the nationwide presence of rivals, mergers, and acquisitions pertaining to gynaecological devices accelerates market expansion. For instance, in October 2021, Hologic, Inc., signed a final agreement to purchase Bolder Surgical, for about USD 160 million, subject to working capital and other customary closing adjustments.

How will the Increasing Awareness of Women's Health Issues Supports the Market Growth in the Asia-Pacific (APAC)?

The Asia-Pacific (APAC) region is estimated to grow at a highest CAGR during the forecast period, driven by increasing awareness of women's health issues, improving healthcare infrastructure, and rising disposable incomes. According to a recent report by the World Health Organization (WHO) published on March 15, 2024, the prevalence of gynecological disorders in the APAC region has increased by 12% over the past five years, highlighting the urgent need for advanced medical devices.

Key players in the gynecology devices market are actively pursuing opportunities in the APAC region through strategic partnerships and product launches. For instance, on September 12, 2023, Medtronic, a leading medical technology company, announced the establishment of a new research and development center in Singapore, focusing on innovative gynecological devices tailored to the specific needs of Asian women.

Competitive Landscape

The global Gynecological Devices Market is a dynamic and competitive landscape, with a mix of established players and emerging challengers vying for market share. These players are actively working to strengthen their presence by implementing strategic plans such as collaborations, mergers, acquisitions, and political support. The organizations are dedicated to continuously improving their product line to meet the needs of a wide range of customers in different regions.

Some of the key players operating in the global Gynecological Devices Market include:

Medtronic plc, Cooper Surgical, Inc., Richard Wolf GmbH, Hologic, Inc., Boston Scientific Corp., Stryker Corp., Karl Storz GmbH & Co. KG, Ethicon, Inc. (Johnson & Johnson MedTech), Cook Medical, Bayer AG, Gynemed, Gynex Corp.

Latest Developments

In September 2022, The Guardenia Contained Extraction System was introduced by Olympus, a leading worldwide technology company that designs and provides cutting-edge solutions for medical and surgical procedures.

In June 2022, the new Hystero-V, a single-use hysteroscope was introduced by UroViu Corp. With its hydrophilic covering, the 12-Fr semi-rigid Hystero-V allows for a smooth insertion and enhanced visualization for incredibly successful intrauterine exams.

On July 2021, the Hugo Robotic-Assisted Surgery (RAS) system, developed by Medtronic Plc, was utilized to execute the first gynaecological treatment in Panama.

1 INTRODUCTION OF GLOBAL GYNECOLOGICAL DEVICES MARKET

1.1 Overview
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL GYNECOLOGICAL DEVICES MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL GYNECOLOGICAL DEVICES MARKET, BY PRODUCT

5.1 Overview
5.2 Surgical Devices
- 5.2.1 Gynecological Endoscopy Devices
- 5.2.1.1 Hysteroscope
- 5.2.1.2 Colposcope
- 5.2.1.3 Resectoscope
- 5.2.1.4 Laparoscope
- 5.2.2 Endoscopic imaging systems
- 5.2.2.1 Endometrial Ablation Devices
- 5.2.2.2 Hydrothermal Ablation Devices
- 5.2.2.3 Radiofrequency Ablation Devices
- 5.2.2.4 Balloon Ablation Devices
- 5.2.2.5 Others (Microwave, Laser)
- 5.2.3 Fluid Management Systems
- 5.2.4 Female Sterilization/Contraceptive Devices
- 5.2.4.1 Permanent Birth Control
- 5.2.4.2 Intra Uterine Devices (IUD)
- 5.2.4.3 Intravaginal rings
- 5.2.4.4 Subdermal Contraceptive Implants
5.3 Handheld Instruments
- 5.3.1 Vaginal Speculum
- 5.3.2 Tenaculum
- 5.3.3 Curettes
- 5.3.4 Trocars Market
- 5.3.5 Biopsy Forceps
- 5.3.6 Others
5.4 Diagnostic Imaging Systems

6 GLOBAL GYNECOLOGICAL DEVICES MARKET, BY END-USER

6.1 Overview
6.2 Hospital & Clinics
6.3 Ambulatory Surgery Centers (ASCs)

7 GLOBAL GYNECOLOGICAL DEVICES MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL GYNECOLOGICAL DEVICES MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Medtronic plc
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Cooper Surgical, Inc.
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Richard Wolf GmbH
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Hologic, Inc.
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Boston Scientific Corp.
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Stryker Corp.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Karl Storz GmbH & Co. KG
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 Ethicon, Inc. (Johnson & Johnson MedTech)
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Cook Medical
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Bayer AG
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments